MENLO PARK, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the appointment of David ...

PacBio (PACB) announced the appointment of David Ruggiero as the company’s new Global Head of Sales & Service. Ruggiero served as Senior ...

I don’t think proteomics will win over genomics," Sanghera said. "They go hand-in-glove. We’ve been overly focused [on genomics], and now we’re going to see an emergence of proteomics. And when the ...

Cancer is a disease of the genome, according to Dr. Elli Papaemmanuil, computational oncologist at MSK. By looking at the ...

On January 13, the technology company announced the development of its first whole-genome sequencing test, xH, using artificial intelligence. This test aims to enhance precision medicine and ...

Gordon Sanghera, Co-Founder and CEO of Oxford Nanopore Technologies, talks about opportunities for DNA and RNA sequencing from the JPM Health Conference. Hosts: Carol Massar and Tim Stenovec.

We recently published a list of 15 Important AI News and Ratings on Investors’ Radar. In this article, we are going to take a look at where Tempus AI, Inc (NASDAQ:TEM) stands against other ...

“Just like volunteering to be an organ donor on your driver’s license is a simple act of service with a profound impact, the Truveta Genome Project enables each of us to anonymously contribute ...

Prime Minister Narendra Modi unveiled the genome sequencing data of 10,000 Indian nationals, marking a significant milestone in biotechnology research. This national database will aid in treating ...